Showing 711-720 of 1520 results for "".
MATV News: Avoiding Serious Complications from Injectable Fillers
https://modernaesthetics.com/series/matv-news/matv-news-avoiding-serious-complications-from-injectable-fillers/33255/Soft-tissue fillers continue to rise in popularity among US consumers seeking aesthetic treatments. And although severe complications from dermal fillers are uncommon, they do unfortunately occur, and treating physicians must understand the risks and be prepared to treat complications. In this speciMATV News: New FDA Approved Cellulite Treatment; Global Alliance Takes on Patient Safety, Medical Tourism
https://modernaesthetics.com/series/matv-news/matv-news-new-fda-approved-cellulite-treatment-global-alliance-takes-on-patient-safety-medical-tourism/33354/The International Society of Aesthetic Plastic Surgery forms a new Global Alliance to advise and consult on all concerns relating to cosmetic surgery, including medical tourism. Could breast implant size selection systems based on breast tissue measurements provide better outcomes? Also, Syneron Can- ASLMS 2025: E. Victor Ross, MD, Talks Landscape of Fractional Laser Treatmentshttps://modernaesthetics.com/news/aslms-2025-e-victor-ross-md-talks-landscape-of-fractional-laser-treatments/2475359/At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations. Risk, Recovery, and Pigmenta
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- Aesthetics Biomedical, Skinceuticals Partner with Vivace Experience Featuring SkinCeuticals C E Ferulichttps://modernaesthetics.com/news/aesthetics-biomedica-skinceuticals-partner-with-vivace-experience-featuring-skinceuticals-c-e-ferulic/2473001/SkinCeuticals is teaming up with Aesthetics Biomedical’s Vivace Fractional Micro Needle Radio Frequency Treatment to create the professional Vivace Experience featuring SkinCeuticals C E Ferulic MaryAnn Guerra, CEO & President of Aesthetics Biomedical states, "Aesthetics
- Bonti's Novel Neurotoxin Shows Promise in Early Study of Scar Reduction After Mohs Surgeryhttps://modernaesthetics.com/news/bontis-novel-neurotoxin-shows-promise-in-early-study-of-scar-reduction-after-mohs-surgery/2472052/Topline results from Bonti’s SHINE-1 Phase 2a clinical trial suggest that its novel neurotoxin is safe and likely effective for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E (BoNT/E) with a unique clinical
- Allergan Reports Positive Phase 3 Data for New Short-acting Neurotoxinhttps://modernaesthetics.com/news/allergans-trenibotulinumtoxine-bonte-smoothes-glabellar-lines-quickly/2473513/Allergan Aesthetics’ trenibotulinumtoxinE (BoNT/E) performed well for the treatment of moderate to severe glabellar lines, according to topline results from two pivotal Phase 3 studies. BoNT/E is a novel botulinum neurotoxin serotype E with a quick onset of action
- Estée Lauder and Atropos Therapeutics Team Up to Discover Senomodulatorshttps://modernaesthetics.com/news/estee-lauder-and-atropos-therapeutics-team-up-to-discover-senomodulators/2472980/The Estée Lauder Companies and Atropos Therapeutics are joining forces to discover botanical senomodulators or senescence-modulating chemicals. Atropos Therapeutics Inc. has a proprietary platform to identify a
- Dr. Arthur Swift is Advanced Medaesthetic Partners’s New CMOhttps://modernaesthetics.com/news/dr-arthur-swift-is-advanced-medaesthetic-partnerss-new-cmo/2473400/Canadian plastic surgeon Arthur Swift, MD, is Advanced Medaesthetic Partners’s new Chief Medical Officer (CMO). “Dr. Swift brings a wealth of knowledge and experience that will be a key asset for our organization,” says Nicole Chiaramonte, AMP CEO, in a news
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di